And during the treatment of KXYA on HBV-related HCC, expression of EGFR, HDAC1, HNF4A, MAPK8, NR3C1, and PTEN could be regulated, which were considered as further research targets. This evidence concerns the gene EGFR and hepatocellular carcinoma.